Business Context and Reporting Period
This Form 6-K filing by AMBEV S.A. covers the reporting period of July 1, 2026, to July 31, 2026, filed on August 10, 2026. The document reports consolidated transactions of securities and derivatives involving the company's Board of Directors, Management, and Fiscal Council in compliance with Article 11 of CVM Instruction # 44/2021.
Key Financial Metrics and Transactions
The filing does not provide consolidated revenue, profit, cash flow, or debt metrics. It details specific insider trading activities:
- Board of Directors: Sold 468,040 ADRs (Common) via J.P. Morgan on July 30, 2026, at a price of R$ 15.64600, totaling a volume of R$ 7,322,953.84. Final ADR balance is 0.
- Management: Received 203,463 Common Shares via direct delivery of restricted shares on July 2, 2026, at a price of R$ 16.20000, totaling a volume of R$ 3,296,100.60. Final Common Share balance is 3,501,801.
- Fiscal Council: Held 2,500 Common Shares with no transactions reported during the period.
Material Changes
Material changes are limited to the reduction of the Board of Directors' ADR holdings to zero and an increase in Management's Common Share holdings due to restricted share vesting. No other material changes to the company's financial position are disclosed in this filing.
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, management commentary on operations, risks, contingencies, or unusual items. The document is strictly a regulatory disclosure of insider securities transactions.
Investor Verification Checklist
- Verify the impact of the Board of Directors' complete liquidation of ADR holdings on market sentiment.
- Confirm the vesting schedule and performance conditions associated with the 203,463 restricted shares delivered to Management.
- Review the company's Form 20-F for comprehensive financial performance data, as this Form 6-K contains no operational metrics.